glp-1 providers drugs have a broad impact on patients, providers, the economy Full Range of FDA-Approved GLP-1s

The thyroid axis supports metabolic rate, temperature regulation, cognition, and energy availability

Long-acting IGF-1 activity Reduced IGFBP binding leaves more available, giving a longer half-life and about three times the potency of native IGF-1

Safety The available clinical data suggest that L-carnitine is generally well tolerated and has been safely used in clinical trials at doses from 250mg to 6g per day for up to six months

Results from a study examining the safety of using liraglutide in patients with moderate to severe renal impairment demonstrated no deleterious effects on serum creatinine (SCr) or increased incidence or severity of adverse events